Ramucirumab

CAS No. 947687-13-0

Ramucirumab( —— )

Catalog No. M30048 CAS No. 947687-13-0

Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 484 In Stock
10MG 699 In Stock
25MG 1071 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock

Biological Information

  • Product Name
    Ramucirumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.
  • Description
    Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    947687-13-0
  • Formula Weight
    6369.07
  • Molecular Formula
    C285H434N74O88S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3',4',7-Trimethoxyqu...

    3',4',7-Trimethoxyquercetin is a polymethoxyquercetin isolated from Scutellaria baicalensis with antioxidant activity.

  • BT18

    BT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF).

  • RR-11a analog

    RR-11a analog is a potent and selective asparaginyl endopeptidases (AE) (Legumain) inhibitors(IC50 values of 4.5 nM, 4.5 nM and 31 nM for AE1 in Trichomonas Vaginalis, AE in Ixodes ricinus and AE in Schistosoma mansoni, respectively).